Gherardi M, Amato A, Bouly JP, Cheminant S, Ferrante MI, d'Alcalá MR, Iudicone D, Falciatore A, Cosentino Lagomarsino M

Regulation of chain length in two diatoms as a growth-fragmentation process.

Phys Rev E 2016; 022418. doi: 10.1103/PhysRevE.94.022418

Geginat J, Larghi P, Paroni M, Nizzoli G, Penatti A, Pagani M, Gagliani N, Meroni P, Abrignani S, Flavell RA

The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer.

Cytokine Growth Factor Rev 2016; 87-93. doi: 10.1016/j.cytogfr.2016.02.003

Holz FG, Tadayoni R, Beatty S, Berger AR, Cereda MG, Hykin P, Staurenghi G, Wittrup-Jensen K, Nilsson J, Kim K, Sivaprasad S

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study.

Eye (Lond) 2016; 1063-71. doi: 10.1038/eye.2016.90

Zanconato F, Battilana G, Cordenonsi M, Piccolo S

YAP/TAZ as therapeutic targets in cancer.

Curr Opin Pharmacol 2016; 26-33. doi: 10.1016/j.coph.2016.05.002

Ashton TM, Fokas E, Kunz-Schughart LA, Folkes LK, Anbalagan S, Huether M, Kelly CJ, Pirovano G, Buffa FM, Hammond EM, Stratford M, Muschel RJ, Higgins GS, McKenna WG

The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.

Nat Commun 2016; 12308. doi: 10.1038/ncomms12308

Garibaldi F, Falcone E, Trisciuoglio D, Colombo T, Lisek K, Walerych D, Del Sal G, Paci P, Bossi G, Piaggio G, Gurtner A

Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex.

Oncogene 2016; 3760-70. doi: 10.1038/onc.2016.51

Reber S, Stettler J, Filosa G, Colombo M, Jutzi D, Lenzken SC, Schweingruber C, Bruggmann R, Bachi A, Barabino SM, Mühlemann O, Ruepp MD

Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants.

EMBO J 2016; 1504-21. doi: 10.15252/embj.201593791

Paroni M, Magarotto A, Tartari S, Nizzoli G, Larghi P, Ercoli G, Gianelli U, Pagani M, Elli L, Abrignani S, Conte D, Geginat J, Caprioli F

Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy.

Clin Transl Gastroenterol 2016; e182. doi: 10.1038/ctg.2016.41

Bonner JN, Choi K, Xue X, Torres NP, Szakal B, Wei L, Wan B, Arter M, Matos J, Sung P, Brown GW, Branzei D, Zhao X

Smc5/6 Mediated Sumoylation of the Sgs1-Top3-Rmi1 Complex Promotes Removal of Recombination Intermediates.

Cell Rep 2016; 368-378. doi: 10.1016/j.celrep.2016.06.015

Cereda M, Gambardella G, Benedetti L, Iannelli F, Patel D, Basso G, Guerra RF, Mourikis TP, Puccio I, Sinha S, Laghi L, Spencer J, Rodriguez-Justo M, Ciccarelli FD

Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes.

Nat Commun 2016; 12072. doi: 10.1038/ncomms12072

Sánchez-Martín FJ, Bellosillo B, Gelabert-Baldrich M, Dalmases A, Cañadas I, Vidal J, Martinez A, Argilés G, Siravegna G, Arena S, Koefoed K, Visa L, Arpí O, Horak ID, Iglesias M, Stroh C, Kragh M, Rovira A, Albanell J, Tabernero J, Bardelli A, Montagut C

The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer.

Clin Cancer Res 2016; 3260-7. doi: 10.1158/1078-0432.CCR-15-2400

Raducu M, Fung E, Serres S, Infante P, Barberis A, Fischer R, Bristow C, Thézénas ML, Finta C, Christianson JC, Buffa FM, Kessler BM, Sibson NR, Di Marcotullio L, Toftgård R, D'Angiolella V

SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development.

EMBO J 2016; 1400-16. doi: 10.15252/embj.201593374

Kajiho H, Kajiho Y, Frittoli E, Confalonieri S, Bertalot G, Viale G, Di Fiore PP, Oldani A, Garre M, Beznoussenko GV, Palamidessi A, Vecchi M, Chavrier P, Perez F, Scita G

RAB2A controls MT1-MMP endocytic and E-cadherin polarized Golgi trafficking to promote invasive breast cancer programs.

EMBO Rep 2016; 1061-80. doi: 10.15252/embr.201642032

Nizzoli G, Larghi P, Paroni M, Crosti MC, Moro M, Neddermann P, Caprioli F, Pagani M, De Francesco R, Abrignani S, Geginat J

IL-10 promotes homeostatic proliferation of human CD8(+) memory T cells and, when produced by CD1c(+) DCs, shapes naive CD8(+) T-cell priming.

Eur J Immunol 2016; 1622-32. doi: 10.1002/eji.201546136

Haider S, McIntyre A, van Stiphout RG, Winchester LM, Wigfield S, Harris AL, Buffa FM

Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.

Genome Biol 2016; 140. doi: 10.1186/s13059-016-0999-8

Felli N, Errico MC, Pedini F, Petrini M, Puglisi R, Bellenghi M, Boe A, Felicetti F, Mattia G, De Feo A, Bottero L, Tripodo C, Carè A

AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression.

Oncogene 2016; 3016-26. doi: 10.1038/onc.2015.357

Kabanova A, Marcandalli J, Zhou T, Bianchi S, Baxa U, Tsybovsky Y, Lilleri D, Silacci-Fregni C, Foglierini M, Fernandez-Rodriguez BM, Druz A, Zhang B, Geiger R, Pagani M, Sallusto F, Kwong PD, Corti D, Lanzavecchia A, Perez L

Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer.

Nat Microbiol 2016; 16082. doi: 10.1038/nmicrobiol.2016.82

Amatu A, Barault L, Moutinho C, Cassingena A, Bencardino K, Ghezzi S, Palmeri L, Bonazzina E, Tosi F, Ricotta R, Cipani T, Crivori P, Gatto R, Chirico G, Marrapese G, Truini M, Bardelli A, Esteller M, Di Nicolantonio F, Sartore-Bianchi A, Siena S

Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer.

Ann Oncol 2016; 1062-1067. doi: 10.1093/annonc/mdw071

Pozzi C, Cuomo A, Spadoni I, Magni E, Silvola A, Conte A, Sigismund S, Ravenda PS, Bonaldi T, Zampino MG, Cancelliere C, Di Fiore PP, Bardelli A, Penna G, Rescigno M

The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death.

Nat Med 2016; 624-31. doi: 10.1038/nm.4078

Petrakis TG, Komseli ES, Papaioannou M, Vougas K, Polyzos A, Myrianthopoulos V, Mikros E, Trougakos IP, Thanos D, Branzei D, Townsend P, Gorgoulis VG

Exploring and exploiting the systemic effects of deregulated replication licensing.

Semin Cancer Biol 2016; 3-15. doi: 10.1016/j.semcancer.2015.12.002

Bedogni F, Cobolli Gigli C, Pozzi D, Rossi RL, Scaramuzza L, Rossetti G, Pagani M, Kilstrup-Nielsen C, Matteoli M, Landsberger N

Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.

Cereb Cortex 2016; 2517-2529. doi: 10.1093/cercor/bhv078

Sartore-Bianchi A, Trusolino L, Martino C, Bencardino K, Lonardi S, Bergamo F, Zagonel V, Leone F, Depetris I, Martinelli E, Troiani T, Ciardiello F, Racca P, Bertotti A, Siravegna G, Torri V, Amatu A, Ghezzi S, Marrapese G, Palmeri L, Valtorta E, Cassingena A, Lauricella C, Vanzulli A, Regge D, Veronese S, Comoglio PM, Bardelli A, Marsoni S, Siena S

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.

Lancet Oncol 2016; 738-746. doi: 10.1016/S1470-2045(16)00150-9

Frago S, Nicholls RD, Strickland M, Hughes J, Williams C, Garner L, Surakhy M, Maclean R, Rezgui D, Prince SN, Zaccheo OJ, Ebner D, Sanegre S, Yu S, Buffa FM, Crump MP, Hassan AB

Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist.

Proc Natl Acad Sci U S A 2016; E2766-75. doi: 10.1073/pnas.1513023113

Terré B, Piergiovanni G, Segura-Bayona S, Gil-Gómez G, Youssef SA, Attolini CS, Wilsch-Bräuninger M, Jung C, Rojas AM, Marjanović M, Knobel PA, Palenzuela L, López-Rovira T, Forrow S, Huttner WB, Valverde MA, de Bruin A, Costanzo V, Stracker TH

GEMC1 is a critical regulator of multiciliated cell differentiation.

EMBO J 2016; 942-60. doi: 10.15252/embj.201592821

El Sayyed H, Le Chat L, Lebailly E, Vickridge E, Pages C, Cornet F, Cosentino Lagomarsino M, Espéli O

Mapping Topoisomerase IV Binding and Activity Sites on the E. coli Genome.

PLoS Genet 2016; e1006025. doi: 10.1371/journal.pgen.1006025

Pusceddu S, Buzzoni R, Vernieri C, Concas L, Marceglia S, Giacomelli L, Milione M, Leuzzi L, Femia D, Formisano B, Mazzaferro V, de Braud F

Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.

Future Oncol 2016; 1251-60. doi: 10.2217/fon-2015-0077

D'Artista L, Bisso A, Piontini A, Doni M, Verrecchia A, Kress TR, Morelli MJ, Del Sal G, Amati B, Campaner S

Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc.

Oncotarget 2016; 21786-98. doi: 10.18632/oncotarget.7846

Monzo P, Chong YK, Guetta-Terrier C, Krishnasamy A, Sathe SR, Yim EK, Ng WH, Ang BT, Tang C, Ladoux B, Gauthier NC, Sheetz MP

Mechanical confinement triggers glioma linear migration dependent on formin FHOD3.

Mol Biol Cell 2016; 1246-61. doi: 10.1091/mbc.E15-08-0565

Vecchione L, Gambino V, Raaijmakers J, Schlicker A, Fumagalli A, Russo M, Villanueva A, Beerling E, Bartolini A, Mollevi DG, El-Murr N, Chiron M, Calvet L, Nicolazzi C, Combeau C, Henry C, Simon IM, Tian S, in 't Veld S, D'ario G, Mainardi S, Beijersbergen RL, Lieftink C, Linn S, Rumpf-Kienzl C, Delorenzi M, Wessels L, Salazar R, Di Nicolantonio F, Bardelli A, van Rheenen J, Medema RH, Tejpar S, Bernards R

A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility.

Cell 2016; 317-30. doi: 10.1016/j.cell.2016.02.059

Findlay JM, Castro-Giner F, Makino S, Rayner E, Kartsonaki C, Cross W, Kovac M, Ulahannan D, Palles C, Gillies RS, MacGregor TP, Church D, Maynard ND, Buffa F, Cazier JB, Graham TA, Wang LM, Sharma RA, Middleton M, Tomlinson I

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.

Nat Commun 2016; 11111. doi: 10.1038/ncomms11111

Gherardi M, Bassetti F, Cosentino Lagomarsino M

Law of corresponding states for open collaborations.

Phys Rev E 2016; 042307. doi: 10.1103/PhysRevE.93.042307

Wollscheid HP, Biancospino M, He F, Magistrati E, Molteni E, Lupia M, Soffientini P, Rottner K, Cavallaro U, Pozzoli U, Mapelli M, Walters KJ, Polo S

Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain.

Nat Struct Mol Biol 2016; 300-308. doi: 10.1038/nsmb.3187

He F, Wollscheid HP, Nowicka U, Biancospino M, Valentini E, Ehlinger A, Acconcia F, Magistrati E, Polo S, Walters KJ

Myosin VI Contains a Compact Structural Motif that Binds to Ubiquitin Chains.

Cell Rep 2016; 2683-94. doi: 10.1016/j.celrep.2016.01.079

Bonci D, Coppola V, Patrizii M, Addario A, Cannistraci A, Francescangeli F, Pecci R, Muto G, Collura D, Bedini R, Zeuner A, Valtieri M, Sentinelli S, Benassi MS, Gallucci M, Carlini P, Piccolo S, De Maria R

A microRNA code for prostate cancer metastasis.

Oncogene 2016; 1180-92. doi: 10.1038/onc.2015.176

%PLACEHOLDER%